AI Pharmaceutical

BRIEF: XtalPi shares surge on Microsoft China partnership

AI pharmaceutical company XtalPi Holdings Ltd. (2228.HK) on Monday announced it has entered into a strategic cooperation memorandum with Microsoft China for new drug and materials development. Under the tie-up, the…
2228.HK

Recent Articles

RECENT ARTICLES

  1. XtalPi deploys artificial intelligence in drug discovery
    NEWS WRAP: Surging Xtalpi seizes on tech rally to raise $267 million
    2228.HK
  2. Yunji rides robotics wave to Hong Kong IPO with A-list of backers
  3. Everest Medicines drives growth with AI-powered mRNA pipeline
    1952.HK
  4. Everest gets boost from core product Nefecon’s inclusion in China’s national health plan
    1952.HK
  5. As Covid drug cash dwindles, Vigonvita targets new remedies
  6. Cancer drug maker Genfleet joins Hong Kong IPO influx
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva